# A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C

> **NCT00814606** · PHASE2 · WITHDRAWN · sponsor: **University of Chicago**

## Conditions studied

- Hepatitis C
- Hepatitis C Virus

## Interventions

- **DRUG:** Fluvastatin
- **DRUG:** Peginterferon alfa2a
- **DRUG:** ribavirin

## Key facts

- **NCT ID:** NCT00814606
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no one ever enrolled
- **Last updated:** 2013-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00814606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00814606, "A Pilot Trial to Determine the Safety and Efficacy of Fluvastatin in Previous Partial Responders to Pegylated Interferon and Ribivirin in Patients With Genotype 1 Hepatitis C". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00814606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*